rfhg_78242.1

Basic information about the TSS

---

TSS ID: rfhg_78242.1 Species: human Chr: chr6		Start: 13814432 End: 13814580 Strand: -
Source datasets	PRJNA4843412|DRA013844|PRJNA401781|PRJNA548673|PRJNA615891
Protocol	NETCAGE|CAGE|ReCappable-seq|SLIC_CAGE
TSS cluster detected*	6

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3815458,EH38E2447770)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000379170.8:0 ENST00000488770.1:0 BC016850:0 GQ891536:0 AK024611:0 GeneID: 63933 HGNC/MGI_ID: HGNC:21097 UniProt_ID: A0A384NPW7 Q96AQ8 Nearer transcript ids and distances: KJ894516:3 BC008234:117 view more...

Gene_name: mitochondrial calcium uniporter regulator 1 Gene_symbol: MCUR1 Gene_synonyms: FLJ20958 Gene_source: HGNC:21097

TATA-Box annotation

---

Distance to TSS:	54
Nearest PromoterID:	NM_001031713
Entrez ID:	63933
Nearest Unigene:	Hs.214043
Nearest Refseq:	NM_022102
Nearest Ensembl:	ENSG00000050393
Gene Name:	mitochondrial calcium uniporter regulator 1
Gene Alias:	C6orf79|CCDC90A|FMP32
Gene Type:	protein-coding
CpG%:	0.155405
GC%:	0.765101
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MCUR1 p2@MCUR1
Sample		p1@MCUR1	p2@MCUR1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	4.48	25.32
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	5.46	31.97
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.14	26.23
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	5.82	23.91
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	7.42	23.85
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.59	22.29
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	9.37	37.91
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.27	32.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	8.55	33.34
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	6.96	22.03
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	8.08	17.79
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	6.91	18.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	7.25	7.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	6.47	4.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	6.59	7.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	4.28	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	5.68	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	5.91	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	4.80	4.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	6.17	6.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	6.42	8.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	5.70	7.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	7.50	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	6.55	7.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	6.97	6.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.55	7.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	6.04	9.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.61	9.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	6.30	8.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.60	7.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.54	9.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	6.84	7.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	8.02	8.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	4.29	5.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	5.61	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	6.13	8.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.15	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	5.84	8.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	6.21	7.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	8.64	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	7.06	7.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	4.83	8.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.96	9.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	6.47	7.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.04	13.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.77	11.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	7.92	11.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.15	12.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	7.18	10.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	7.48	10.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	6.76	12.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	6.45	10.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	7.45	9.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	3.98	9.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	14.26	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	5.51	9.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	6.81	9.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	10.60	11.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.54	8.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	7.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	10.65	8.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	3.18	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	3.74	4.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.47	7.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.10	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	31.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.31	11.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.42	11.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.44	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	7.29	7.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.99	12.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.37	10.40
Adipocyte - breast, donor1	11376-118A8	17.11	11.25
Adipocyte - breast, donor2	11327-117E4	16.36	13.64
Adipocyte - omental, donor1	11473-119C6	16.41	10.81
Adipocyte - omental, donor2	11474-119C7	2.99	8.22
Adipocyte - omental, donor3	11475-119C8	8.37	9.38
Adipocyte - perirenal, donor1	11476-119C9	15.31	7.02
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	9.90
Adipocyte - subcutaneous, donor2	11336-117F4	7.68	7.23
Adipocyte - subcutaneous, donor3	11408-118E4	6.26	7.12
Adipocyte differentiation, day04, donor1	13019-139D4	13.89	9.39
Adipocyte differentiation, day04, donor2	13022-139D7	8.49	4.89
Adipocyte differentiation, day04, donor3	13025-139E1	16.17	10.31
Adipocyte differentiation, day04, donor4	13028-139E4	11.76	7.64
Adipocyte differentiation, day08, donor1	13020-139D5	16.89	10.86
Adipocyte differentiation, day08, donor2	13023-139D8	10.97	6.78
Adipocyte differentiation, day08, donor3	13026-139E2	9.60	8.53
Adipocyte differentiation, day08, donor4	13029-139E5	15.02	9.46
Adipocyte differentiation, day12, donor1	13021-139D6	13.31	7.07
Adipocyte differentiation, day12, donor2	13024-139D9	9.54	7.03
Adipocyte differentiation, day12, donor3	13027-139E3	13.74	9.49
Adipocyte differentiation, day12, donor4	13030-139E6	10.66	10.96
Alveolar Epithelial Cells, donor1	11510-119G7	7.96	12.38
Alveolar Epithelial Cells, donor2	11590-120G6	3.59	4.30
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	14.03	10.25
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	8.37
Amniotic Epithelial Cells, donor3	11694-123A2	15.20	7.40
Anulus Pulposus Cell, donor1	11248-116E6	7.90	4.00
Anulus Pulposus Cell, donor2	11463-119B5	3.18	2.69
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.99	3.15
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	5.21	4.78
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	8.67	5.68
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	7.59	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	4.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.82	4.55
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	10.68	4.85
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.03	4.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.53	5.27
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	12.34	7.26
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	6.27	5.02
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.85	7.58
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	5.46
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	13.57	6.48
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.43	4.29
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.07	4.91
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	9.62	5.08
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.62	6.14
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	4.80
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	7.08
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.09	4.46
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.83	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	12.52	3.42
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.41	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.12	4.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.78	5.16
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.57	4.69
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.65	6.43
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	5.26
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.54	5.12
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.63	3.05
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	9.42	4.58
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	6.99
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	4.32
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.47	4.66
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.25	6.38
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	5.67
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.48	4.07
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	4.23	12.68
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	11.15	3.65
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.83	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.75	5.10
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	11.26	3.45
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	13.47	6.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.73	6.40
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.24	5.20
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.13	7.17
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	11.09	4.21
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	10.68	6.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.08	4.43
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.65	2.91
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	9.09	4.72
Astrocyte - cerebellum, donor1	11500-119F6	12.28	11.67
Astrocyte - cerebellum, donor2	11580-120F5	10.44	10.61
Astrocyte - cerebellum, donor3	11661-122F5	10.91	6.08
Astrocyte - cerebral cortex, donor1	11235-116D2	29.28	15.34
Astrocyte - cerebral cortex, donor2	11316-117D2	23.78	11.65
Astrocyte - cerebral cortex, donor3	11392-118C6	25.80	15.81
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	13.30	27.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	12.65	30.32
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	12.97	26.06
Basophils, donor1	12241-129G9	4.97	3.14
Basophils, donor2	12242-129H1	7.58	4.69
Basophils, donor3	12243-129H2	6.91	5.29
Bronchial Epithelial Cell, donor1	11511-119G8	7.76	6.47
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	5.65	9.41
Bronchial Epithelial Cell, donor5	11457-119A8	4.99	6.03
Bronchial Epithelial Cell, donor6	11461-119B3	2.76	8.06
Bronchial Epithelial Cell, donor7	11769-123I5	8.28	6.84
Burkitt's lymphoma cell line:DAUDI	10422-106C8	18.24	25.97
Burkitt's lymphoma cell line:RAJI	10476-106I8	26.78	37.03
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	18.23	17.27
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34
CD14+ Monocytes, donor1	11224-116B9	5.64	3.38
CD14+ Monocytes, donor2	11305-117B9	5.38	2.78
CD14+ Monocytes, donor3	11381-118B4	6.15	4.17
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	15.85	6.23
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	13.65	6.07
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	15.12	3.62
CD14+ monocytes - mock treated, donor1	11863-125A9	4.48	5.35
CD14+ monocytes - mock treated, donor2	11873-125C1	3.02	2.11
CD14+ monocytes - mock treated, donor3	11883-125D2	3.08	3.79
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	3.52	3.68
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	2.21	6.62
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	3.22	5.45
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.33	2.55
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1.60	3.56
CD14+ monocytes - treated with BCG, donor3	11880-125C8	3.92	5.01
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.04	4.68
CD14+ monocytes - treated with Candida, donor2	11878-125C6	3.70	3.17
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	3.33
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1.64	5.21
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	2.99	3.79
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.12	5.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.06	2.52
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.90	3.85
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1.75	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	2.69	3.50
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	2.09	3.14
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	4.63	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.57	3.31
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.06	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	2.19	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.36	4.53
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	2.23	2.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	4.31	3.66
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.28	2.46
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.55	2.78
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.09	3.25
CD14+CD16+ Monocytes, donor1	11789-124B7	9.37	8.28
CD14+CD16+ Monocytes, donor2	11801-124D1	8.78	6.93
CD14+CD16+ Monocytes, donor3	11912-125G4	9.96	6.72
CD14+CD16- Monocytes, donor1	11788-124B6	8.25	7.16
CD14+CD16- Monocytes, donor2	11799-124C8	7.34	5.76
CD14+CD16- Monocytes, donor3	11910-125G2	5.57	2.90
CD14-CD16+ Monocytes, donor1	11790-124B8	8.93	6.12
CD14-CD16+ Monocytes, donor2	11800-124C9	7.03	9.00
CD14-CD16+ Monocytes, donor3	11911-125G3	8.42	6.11
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	16.26	18.29
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	8.81	9.49
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	17.61	20.71
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	10.66	11.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	15.55	13.40
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.02	9.13
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	12.55	7.06
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	13.18	14.50
CD19+ B Cells, donor1	11544-120B5	5.75	2.47
CD19+ B Cells, donor2	11624-122B4	4.35	6.53
CD19+ B Cells, donor3	11705-123B4	8.58	7.57
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	41.21	27.88
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	31.16	29.96
CD34+ Progenitors, donor1	11545-120B6	13.05	10.04
CD34+ Progenitors, donor2	11625-122B5	7.87	3.93
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	18.79	24.42
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	24.58	23.90
CD4+ T Cells, donor1	11225-116C1	4.28	6.43
CD4+ T Cells, donor2	11306-117C1	5.51	5.51
CD4+ T Cells, donor3	11382-118B5	7.01	6.71
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	5.87	9.70
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	7.86	12.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	9.49	9.20
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	5.69	5.22
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	7.73	7.73
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	10.12	11.27
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	8.81	10.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	9.35	8.71
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	8.52	7.62
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	9.08	8.39
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.92	7.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	5.90	5.90
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	11.01	9.77
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	10.69	9.02
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	7.07	8.43
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	4.82	10.72
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	7.17	8.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	13.35	11.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	13.21	9.75
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	10.09	10.93
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	8.60	8.09
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	6.93	7.80
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	10.02	6.54
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	16.33	8.91
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	15.69	12.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	13.96	11.17
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	8.86	3.88
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	7.85	4.91
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	15.40	13.86
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	10.03	5.01
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	13.85	6.92
CD8+ T Cells, donor1	11226-116C2	6.55	4.91
CD8+ T Cells, donor2	11307-117C2	10.89	4.13
CD8+ T Cells, donor3	11383-118B6	8.33	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.80	31.66
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.95	22.29
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	7.93	27.63
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	11.11	27.62
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	5.52	26.88
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	8.41	30.70
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	11.95	37.59
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	9.21	31.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	7.04	37.05
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	13.58	31.70
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	10.46	28.76
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	12.52	27.71
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	7.00	13.57
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	7.74	15.03
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	5.97	8.95
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.28	28.09
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	7.77	31.65
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	7.54	25.93
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	11.73	33.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	10.15	35.68
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.26	31.42
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	12.24	24.10
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	13.01	29.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.83	24.96
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	1.61	12.04
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	6.29	16.09
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	3.01	15.03
Cardiac Myocyte, donor1	11525-119I4	1.83	3.66
Cardiac Myocyte, donor2	11605-120I3	6.92	5.43
Cardiac Myocyte, donor3	11686-122I3	10.21	10.52
Chondrocyte - de diff, donor1	11261-116G1	15.25	13.87
Chondrocyte - de diff, donor2	11338-117F6	9.95	5.69
Chondrocyte - de diff, donor3	11410-118E6	13.31	7.17
Chondrocyte - re diff, donor2	11339-117F7	19.70	15.22
Chondrocyte - re diff, donor3	11411-118E7	10.92	6.47
Ciliary Epithelial Cells, donor1	11242-116D9	16.18	11.02
Ciliary Epithelial Cells, donor2	11323-117D9	12.61	8.34
Ciliary Epithelial Cells, donor3	11399-118D4	12.12	8.23
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	19.99	14.67
Corneal Epithelial Cells, donor1	11526-119I5	7.25	9.88
Corneal Epithelial Cells, donor2	11606-120I4	9.10	9.10
Corneal Epithelial Cells, donor3	11687-122I4	8.18	9.71
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	42.76	37.48
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	45.10	41.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	58.66	37.96
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	29.05	31.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	10.25	9.57
Dendritic Cells - plasmacytoid, donor2	11309-117C4	14.36	9.14
Dendritic Cells - plasmacytoid, donor3	11385-118B8	4.84	10.16
Endothelial Cells - Aortic, donor0	11207-116A1	7.34	10.17
Endothelial Cells - Aortic, donor1	11263-116G3	1.76	5.87
Endothelial Cells - Aortic, donor2	11340-117F8	6.50	7.07
Endothelial Cells - Aortic, donor3	11412-118E8	4.72	9.04
Endothelial Cells - Artery, donor1	11264-116G4	3.78	3.78
Endothelial Cells - Artery, donor2	11341-117F9	7.53	13.41
Endothelial Cells - Artery, donor3	11413-118E9	4.91	5.08
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.20	8.42
Endothelial Cells - Lymphatic, donor2	11317-117D3	9.13	8.82
Endothelial Cells - Lymphatic, donor3	11393-118C7	7.89	6.20
Endothelial Cells - Microvascular, donor1	11265-116G5	5.94	5.94
Endothelial Cells - Microvascular, donor2	11342-117G1	4.17	8.85
Endothelial Cells - Microvascular, donor3	11414-118F1	7.23	5.96
Endothelial Cells - Thoracic, donor1	11266-116G6	7.60	14.80
Endothelial Cells - Thoracic, donor2	11343-117G2	5.77	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	21.99	16.40
Endothelial Cells - Umbilical vein, donor2	11324-117E1	12.38	7.60
Endothelial Cells - Umbilical vein, donor3	11400-118D5	19.54	13.43
Endothelial Cells - Vein, donor1	11267-116G7	5.69	10.24
Endothelial Cells - Vein, donor2	11344-117G3	2.10	8.38
Endothelial Cells - Vein, donor3	11416-118F3	5.97	12.25
Eosinophils, donor1	12244-129H3	15.25	0.00
Eosinophils, donor2	12245-129H4	1.65	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	6.35	6.35
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	8.32
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.55	6.16
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.09	5.15
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	11.48	12.46
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.65	11.16
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	3.41	4.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	16.45	8.12
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	4.48	5.27
Fibroblast - Aortic Adventitial, donor3	11401-118D6	11.96	13.95
Fibroblast - Cardiac, donor1	11268-116G8	6.80	8.17
Fibroblast - Cardiac, donor2	11345-117G4	6.82	10.61
Fibroblast - Cardiac, donor3	11417-118F4	7.41	8.04
Fibroblast - Cardiac, donor4	11452-119A3	13.34	11.21
Fibroblast - Cardiac, donor5	11456-119A7	9.77	9.26
Fibroblast - Cardiac, donor6	11460-119B2	10.76	8.79
Fibroblast - Choroid Plexus, donor1	11492-119E7	7.50	6.16
Fibroblast - Choroid Plexus, donor2	11572-120E6	6.90	3.88
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	17.58
Fibroblast - Conjunctival, donor1	11531-120A1	10.38	13.61
Fibroblast - Conjunctival, donor3	11692-122I9	15.26	7.63
Fibroblast - Dermal, donor1	11269-116G9	10.10	7.28
Fibroblast - Dermal, donor2	11346-117G5	9.43	10.85
Fibroblast - Dermal, donor3	11418-118F5	13.06	12.81
Fibroblast - Dermal, donor4	11450-119A1	17.86	12.43
Fibroblast - Dermal, donor5	11454-119A5	21.63	21.63
Fibroblast - Dermal, donor6	11458-119A9	29.56	23.71
Fibroblast - Gingival, donor1	11237-116D4	10.00	5.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	14.15	10.22
Fibroblast - Gingival, donor2	11318-117D4	16.87	11.47
Fibroblast - Gingival, donor3	11394-118C8	11.51	9.28
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	12.47	9.35
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.62	10.57
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	17.30	13.87
Fibroblast - Gingival, donor6 (control)	11922-125H5	14.88	9.74
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.59	16.23
Fibroblast - Gingival, donor7 (control)	11924-125H7	16.38	9.65
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	15.68	6.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	16.67	15.14
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.26	6.75
Fibroblast - Lung, donor1	11270-116H1	1.36	4.08
Fibroblast - Lung, donor2	11347-117G6	5.97	8.95
Fibroblast - Lung, donor3	11419-118F6	11.61	14.14
Fibroblast - Lymphatic, donor1	11506-119G3	11.66	11.66
Fibroblast - Lymphatic, donor2	11586-120G2	4.20	12.59
Fibroblast - Lymphatic, donor3	11667-122G2	5.60	7.00
Fibroblast - Mammary, donor1	11540-120B1	18.67	21.92
Fibroblast - Mammary, donor2	11620-122A9	11.98	19.97
Fibroblast - Mammary, donor3	11701-123A9	0.00	17.87
Fibroblast - Periodontal Ligament, donor1	11238-116D5	21.34	11.44
Fibroblast - Periodontal Ligament, donor2	11319-117D5	19.72	13.95
Fibroblast - Periodontal Ligament, donor3	11395-118C9	16.83	11.02
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.26	8.78
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.82	7.56
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	16.24	9.63
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.04	17.24
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	11.18	16.86
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	9.35	11.36
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	11.86	10.67
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	5.16	4.17
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	13.68	8.17
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	9.66	9.07
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	6.32	6.32
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	12.63	7.88
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	3.80	4.30
Fibroblast - skin normal, donor1	11553-120C5	12.31	7.38
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	5.41	11.63
Fibroblast - skin normal, donor2	11561-120D4	15.27	9.14
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	5.44	5.14
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.24	8.37
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	12.82	5.47
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	2.96	3.28
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	15.23	8.20
Fibroblast - skin walker warburg, donor1	11554-120C6	11.81	9.28
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.45	5.33
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	29.63	11.33
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	15.78	12.83
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	16.92	11.19
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	9.20	7.92
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	23.73	21.44
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	31.27	21.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	44.22	15.69
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	42.47	17.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	27.63	15.07
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	37.64	14.27
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	50.22	14.27
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	35.55	15.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	31.84	12.82
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	25.58	9.61
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	22.54	7.51
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	24.18	10.48
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	19.70	13.75
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	19.93	13.84
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.65	12.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	29.21	12.78
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.45	10.21
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	14.43	13.33
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	21.57	12.71
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	21.30	11.76
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	23.24	13.18
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	21.57	12.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	19.34	10.86
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	22.35	16.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.85	13.32
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	21.35	9.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	17.37	10.07
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.71	15.06
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.56	12.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.04	9.90
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	14.99	7.38
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	18.34	12.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	20.28	9.04
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.79	9.59
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	19.13	11.83
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	18.92	8.34
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	17.15	9.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.50	9.97
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	21.59	11.86
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.82	9.51
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.13	8.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	21.04	9.82
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	15.46	10.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	17.65	16.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	21.73	15.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	16.06	14.90
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	20.60	13.82
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	15.67	7.19
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	15.57	8.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	10.91	6.94
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	16.75	8.05
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	14.53	6.86
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	14.74	6.61
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	26.28	11.15
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	24.19	8.01
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	33.76	9.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	41.62	20.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	39.56	16.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	22.14	7.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	22.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	30.56	15.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	35.30	9.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	34.78	26.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	36.13	19.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	33.77	14.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	16.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	32.44	12.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	27.13	14.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	31.04	10.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	36.90	12.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	34.65	11.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	41.76	14.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	33.22	12.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	28.12	9.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	18.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	36.86	19.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.91	13.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	27.68	15.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	29.01	9.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	38.12	8.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	29.28	9.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	39.37	13.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	41.05	6.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	28.97	6.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	39.68	9.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	33.10	13.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	31.08	13.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	43.68	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	32.09	8.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	31.16	7.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	26.28	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	29.25	13.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	23.78	7.28
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	5.71
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.81	4.16
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	4.50	14.62
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.39	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	7.52	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	30.40	32.26
Hep-2 cells mock treated, biol_rep2	11899-125E9	29.71	36.80
Hep-2 cells mock treated, biol_rep3	11900-125F1	31.17	36.40
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	31.59	35.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	29.01	33.10
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	23.90	31.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	29.89	33.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	28.82	26.08
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	24.67	27.87
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	8.95	7.28
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	13.42
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	14.11	7.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	4.36
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.32	15.74
Hepatocyte, donor1	11523-119I2	23.00	8.47
Hepatocyte, donor2	11603-120I1	25.86	15.08
Hepatocyte, donor3	11684-122I1	13.50	10.43
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	21.54	28.07
Intestinal epithelial cells (polarized), donor1	11246-116E4	42.47	21.32
Iris Pigment Epithelial Cells, donor1	11530-119I9	9.88	6.86
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	46.73
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	13.84	15.23
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	47.47
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	15.38
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	13.71
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	37.36
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	29.04
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	11.91	33.09
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	6.65	16.63
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	10.08	23.93
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	24.75
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	12.27	16.80
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	12.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	9.78	20.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	5.46	20.15
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	11.25	21.70
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	11.08	16.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.50	20.77
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	7.26	9.98
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	29.48
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	35.51
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	11.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	32.86
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	3.83	21.68
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	16.40
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	31.61
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.14	20.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	19.91
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	11.73	22.22
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	17.56
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	15.72
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	10.43	17.38
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	13.28
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	25.94
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	8.72	13.95
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	15.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	18.14
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	4.16	11.08
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	28.50
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	17.49
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	9.08
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	11.63	9.52
Keratinocyte - epidermal, donor1	11272-116H3	8.24	7.10
Keratinocyte - epidermal, donor2	11349-117G8	5.27	12.30
Keratinocyte - epidermal, donor3	11421-118F8	19.69	15.81
Keratinocyte - oral, donor1	11251-116E9	17.25	12.60
Keratocytes, donor1	11527-119I6	5.50	14.44
Keratocytes, donor2	11607-120I5	9.37	7.03
Keratocytes, donor3	11688-122I5	8.30	8.69
Krukenberg tumor cell line:HSKTC	10687-109F3	8.79	8.79
Lens Epithelial Cells, donor1	11529-119I8	8.63	5.39
Lens Epithelial Cells, donor2	11609-120I7	16.38	5.31
Lens Epithelial Cells, donor3	11690-122I7	7.57	7.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	9.01	7.35
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	5.86	4.74
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	6.30	9.76
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	8.07	5.91
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.93	6.93
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.47	6.79
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	5.75	7.39
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	4.55	6.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5.49	5.49
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	7.12
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	6.59	7.76
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.18	5.55
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	6.62	5.92
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	6.20	5.49
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	7.14	6.59
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.55	6.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	3.12	7.17
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	6.04	6.77
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	8.23	6.58
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.44	5.56
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.97	5.73
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	8.24	3.88
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	6.73	8.62
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	7.42	6.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.15	7.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.49	6.07
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.51	5.86
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	8.94	11.01
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.21	6.77
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.94	5.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	7.27	5.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	5.29	7.61
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.09	6.32
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	5.18	8.89
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.95	7.17
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.67	5.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	6.43	9.01
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.00	10.04
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.14	7.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	8.18	7.82
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	4.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.22	3.27
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	11.10	8.95
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	2.94	4.25
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.24	6.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.55	9.90
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.59	8.96
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.27	5.97
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	18.13
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	6.14	9.97
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	11.13
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.89	13.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	7.74	10.55
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	14.01
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.67	8.24
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	9.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.01	14.02
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	9.60	12.51
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12.60	9.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.48	14.09
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	3.08	15.92
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.41	15.88
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	12.66	10.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.15	14.26
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.67	13.61
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.04	10.39
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	8.59	14.73
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	8.15	13.86
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	13.95	10.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	14.85	11.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	13.39
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.06	13.06
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.06	15.84
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.17	17.15
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.96	10.25
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.85	13.64
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	6.91
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	6.14	15.35
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	6.79	16.42
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	7.38	9.03
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	8.13	9.94
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	12.21
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	12.70
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	10.78	12.63
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	11.20	13.78
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13.70	17.98
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	12.33	11.99
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.24	13.27
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.24	12.80
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	7.22	12.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.44	15.57
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.08	12.12
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	10.00	11.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	11.63
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	10.58	12.69
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	12.40	14.81
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.00	9.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.13	11.50
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	4.44	8.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	14.11
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.55	13.07
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	9.01	9.91
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	3.44	10.33
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.02	7.13
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.60	12.12
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	7.26	9.24
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	10.38	10.90
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	7.00	11.38
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5.59	11.18
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7.07	9.27
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	8.10	9.64
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	7.09	11.14
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	8.65	13.46
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	7.16	13.52
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.08	12.15
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	3.46	6.23
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	4.56	15.96
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	6.20	13.94
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.84	12.70
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	4.12	12.36
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	7.46	15.99
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	3.45	9.19
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	5.66	10.80
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	4.95	13.44
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.38	13.05
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8.32	12.06
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	7.83	14.88
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.01	12.94
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	7.90	11.62
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.69	8.03
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.09	14.97
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	7.27	12.53
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	10.10
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	10.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	6.27	14.82
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	2.30	9.20
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	3.28	12.59
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	5.35	13.36
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	7.54	20.80
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	5.30	12.60
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	6.24
Macrophage - monocyte derived, donor1	11232-116C8	15.27	5.47
Macrophage - monocyte derived, donor2	11313-117C8	20.00	11.74
Macrophage - monocyte derived, donor3	11389-118C3	15.73	10.88
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.74	10.62
Mallassez-derived cells, donor2	11929-125I3	15.21	5.86
Mallassez-derived cells, donor3	11930-125I4	15.98	7.78
Mammary Epithelial Cell, donor1	11273-116H4	12.06	16.04
Mammary Epithelial Cell, donor2	11350-117G9	9.56	14.77
Mammary Epithelial Cell, donor3	11422-118F9	7.48	9.98
Mast cell - stimulated, donor1	11487-119E2	32.54	6.10
Mast cell, donor1	11563-120D6	18.28	8.33
Mast cell, donor2	11565-120D8	7.43	5.05
Mast cell, donor3	11566-120D9	10.13	2.93
Mast cell, donor4	11567-120E1	10.81	5.14
Mast cell, expanded and stimulated, donor5	11940-126A5	15.30	9.98
Mast cell, expanded and stimulated, donor8	11942-126A7	19.26	25.10
Mast cell, expanded, donor5	11939-126A4	14.91	8.60
Mast cell, expanded, donor8	11941-126A6	14.06	9.54
Melanocyte - dark, donor1	11502-119F8	17.81	9.15
Melanocyte - dark, donor2	11582-120F7	7.96	10.38
Melanocyte - dark, donor3	11663-122F7	44.19	20.21
Melanocyte - light, donor1	11274-116H5	11.52	5.17
Melanocyte - light, donor2	11351-117H1	7.51	5.46
Melanocyte - light, donor3	11423-118G1	6.94	11.27
Melanocyte, donor1 (MC+1)	12641-134G4	25.41	15.62
Melanocyte, donor2 (MC+2)	12739-135I3	21.25	12.37
Melanocyte, donor3 (MC+3)	12837-137B2	21.96	5.89
Meningeal Cells, donor1	11493-119E8	14.39	13.89
Meningeal Cells, donor2	11573-120E7	9.68	8.80
Meningeal Cells, donor3	11654-122E7	19.48	18.17
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	17.68	12.83
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	7.95	10.87
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	11.77
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	14.35	15.79
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.92	10.16
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	8.04	9.55
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.31	13.40
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	14.61	23.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	9.41	11.46
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	6.79	4.43
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.81	4.83
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	11.97	8.29
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	5.04	4.75
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	13.45
Mesenchymal stem cells - adipose, donor0	11217-116B2	20.20	24.81
Mesenchymal stem cells - hepatic, donor0	11218-116B3	10.32	7.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	15.97	11.61
Mesothelial Cells, donor1	11247-116E5	6.36	3.98
Mesothelial Cells, donor2	12156-128G5	10.01	2.50
Mesothelial Cells, donor3	11402-118D7	5.42	3.04
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	5.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.49	9.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	14.13	8.54
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	15.81	4.65
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	13.07	8.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	6.95
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	16.77	6.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.64	7.45
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.71	7.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.86	10.69
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	18.58	5.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	16.34	11.02
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.01	5.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	13.71	4.17
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	5.03
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	14.55	8.28
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	12.36	10.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.08	3.32
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.51	6.22
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.25	6.94
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	9.17	5.50
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	14.80	6.22
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	11.34	6.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	11.39	5.69
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	9.63	7.60
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.43	5.98
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.76	9.41
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	12.01	11.05
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.41	8.81
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	11.51	9.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.95	5.69
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	5.12
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.40	7.44
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	8.35
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	4.42
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.62	8.89
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	7.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	3.20	3.55
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.89	7.57
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.07	4.16
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	5.24	5.83
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.64	9.35
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.60	8.35
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	4.62
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	9.68	6.26
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	5.80	4.15
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	8.81	11.14
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.87	5.15
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	9.53	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	9.07	5.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	9.88	5.69
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.37	2.40
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.15	6.37
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	10.84	7.30
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.58	3.79
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.23	5.97
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	15.73	5.90
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	10.43	2.61
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	8.23	8.82
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	12.11	7.50
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	10.30	3.30
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	7.44	4.76
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	11.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	28.52	10.69
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	18.07	5.59
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	28.40	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	28.47	8.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	29.80	9.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.90	4.88
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	23.70	6.92
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	15.95	3.51
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.84	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	17.95	4.03
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	30.46	4.28
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	13.13	5.05
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	32.04	10.96
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	53.12	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	28.61	3.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	41.30	5.67
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	39.27	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	91.35	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	14.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	13.57	12.50
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	17.77	16.20
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	15.35	2.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	15.44	5.84
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	10.46	6.08
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	27.13	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.20	6.12
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	18.38	16.54
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.56	3.77
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	18.83	5.11
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.08	2.43
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.67	4.41
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	10.42	3.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.12	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	11.79	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	11.92	3.76
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.30	4.01
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	15.38	3.18
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.21	3.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	6.24	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.20	4.23
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	14.11	4.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	15.47	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	17.47	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.39	5.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	5.52	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.36	4.46
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	12.70	4.23
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	11.87	2.61
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.88	6.01
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.66	3.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	7.21	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.89	3.17
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	10.22	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	9.84	5.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.62	4.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.59	1.74
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.21	4.98
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	16.76	7.06
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.96	5.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	12.90	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.95	3.06
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	6.65	4.23
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.06	5.53
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	4.74
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	4.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.27	3.15
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.99	4.24
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.03	4.75
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	35.41	5.06
Myoblast, donor1	11241-116D8	10.44	7.70
Myoblast, donor2	11322-117D8	9.59	8.63
Myoblast, donor3	11398-118D3	20.85	11.94
NK T cell leukemia cell line:KHYG-1	10777-110G3	28.75	27.73
Natural Killer Cells, donor1	11230-116C6	5.84	8.00
Natural Killer Cells, donor2	11311-117C6	7.24	3.92
Natural Killer Cells, donor3	11387-118C1	5.71	5.15
Neural stem cells, donor1	11275-116H6	39.56	12.34
Neural stem cells, donor2	11352-117H2	53.92	28.88
Neurons, donor1	11494-119E9	28.45	25.03
Neurons, donor2	11574-120E8	39.41	16.73
Neurons, donor3	11655-122E8	46.86	26.31
Neutrophils, donor1	11233-116C9	1.86	0.93
Neutrophils, donor2	11314-117C9	0.00	0.00
Neutrophils, donor3	11390-118C4	6.11	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	8.67	3.68
Nucleus Pulposus Cell, donor2	11409-118E5	8.79	2.93
Nucleus Pulposus Cell, donor3	11462-119B4	5.41	4.21
Olfactory epithelial cells, donor1	11933-125I7	11.98	5.92
Olfactory epithelial cells, donor2	11934-125I8	11.29	5.50
Olfactory epithelial cells, donor3	11935-125I9	10.90	7.38
Olfactory epithelial cells, donor4	11936-126A1	16.65	4.58
Oligodendrocyte - precursors, donor1	11496-119F2	15.65	9.03
Osteoblast - differentiated, donor1	11276-116H7	10.63	7.02
Osteoblast - differentiated, donor2	11353-117H3	8.00	10.29
Osteoblast - differentiated, donor3	11425-118G3	14.28	10.55
Osteoblast, donor1	11277-116H8	6.45	6.25
Osteoblast, donor2	11354-117H4	16.86	14.75
Osteoblast, donor3	11426-118G4	12.26	11.37
Pancreatic stromal cells, donor1	11249-116E7	15.75	11.37
Pericytes, donor1	11491-119E6	4.56	4.56
Pericytes, donor2	11571-120E5	4.98	3.62
Pericytes, donor3	11652-122E5	5.09	8.34
Perineurial Cells, donor1	11499-119F5	14.69	9.04
Perineurial Cells, donor2	11579-120F4	10.40	9.02
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	11.47	5.74
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	7.84	3.92
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	8.80	6.08
Placental Epithelial Cells, donor1	11278-116H9	7.89	12.68
Placental Epithelial Cells, donor2	11355-117H5	11.09	7.76
Placental Epithelial Cells, donor3	11427-118G5	9.82	8.25
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	17.09	5.06
Preadipocyte - breast, donor1	11467-119B9	13.32	8.82
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	4.05	6.40
Preadipocyte - breast, donor2	11328-117E5	18.46	9.68
Preadipocyte - omental, donor1	11468-119C1	14.71	8.74
Preadipocyte - omental, donor2	11329-117E6	14.84	6.98
Preadipocyte - omental, donor3	11403-118D8	14.61	11.75
Preadipocyte - perirenal, donor1	11469-119C2	8.86	12.80
Preadipocyte - subcutaneous, donor1	11279-116I1	7.06	13.51
Preadipocyte - subcutaneous, donor2	11356-117H6	23.73	20.54
Preadipocyte - subcutaneous, donor3	11428-118G6	18.22	15.84
Preadipocyte - visceral, donor1	11280-116I2	21.98	17.42
Preadipocyte - visceral, donor2	11357-117H7	19.33	14.27
Preadipocyte - visceral, donor3	11429-118G7	17.35	13.17
Prostate Epithelial Cells (polarized), donor1	11253-116F2	35.00	27.91
Prostate Epithelial Cells, donor2	11331-117E8	5.69	5.01
Prostate Epithelial Cells, donor3	11404-118D9	13.17	11.39
Prostate Stromal Cells, donor1	11254-116F3	9.57	14.47
Prostate Stromal Cells, donor2	11332-117E9	9.32	18.47
Prostate Stromal Cells, donor3	11405-118E1	8.24	7.82
Renal Cortical Epithelial Cells, donor1	11516-119H4	11.31	22.99
Renal Cortical Epithelial Cells, donor2	11596-120H3	12.96	12.48
Renal Epithelial Cells, donor1	11517-119H5	6.59	17.25
Renal Epithelial Cells, donor2	11597-120H4	12.09	10.67
Renal Epithelial Cells, donor3	11678-122H4	9.95	10.37
Renal Glomerular Endothelial Cells, donor1	11514-119H2	7.49	9.53
Renal Glomerular Endothelial Cells, donor2	11594-120H1	7.41	9.30
Renal Glomerular Endothelial Cells, donor3	11675-122H1	13.54	10.43
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	2.00
Renal Mesangial Cells, donor1	11518-119H6	12.77	11.66
Renal Mesangial Cells, donor2	11598-120H5	13.79	10.66
Renal Mesangial Cells, donor3	11679-122H5	5.55	5.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	18.25	22.28
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.01	17.29
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.19	16.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	12.19	5.96
Retinal Pigment Epithelial Cells, donor1	11528-119I7	7.39	9.95
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	6.17
Retinal Pigment Epithelial Cells, donor3	11689-122I6	6.77	5.77
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.59	11.23
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	35.74	16.97
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	33.57	14.31
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	35.96	16.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	36.28	18.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	47.87	23.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	55.77	30.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	54.83	29.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	53.14	25.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	52.93	24.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	41.48	16.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	41.75	20.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	48.02	26.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	35.72	18.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	46.25	28.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	53.10	27.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	42.44	17.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	46.40	21.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	55.81	25.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	42.20	18.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	45.17	25.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	50.41	29.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	41.22	17.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	45.41	21.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	42.38	20.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.20	18.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	50.40	26.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	47.15	25.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	38.92	23.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	53.97	25.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	50.28	27.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	42.51	21.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	46.23	21.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	44.91	28.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	43.20	26.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	43.60	20.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	45.69	27.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	39.03	25.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	45.27	20.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	50.73	27.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	34.60	13.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	47.35	23.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	46.38	12.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	34.98	17.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	55.95	24.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	49.58	22.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	43.04	16.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	51.71	29.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	49.26	25.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	49.57	19.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	101.01	41.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	55.98	30.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	50.33	18.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	41.62	32.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	66.80	28.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	34.24	23.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	29.46	28.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	46.28	20.43
Schwann Cells, donor1	11498-119F4	9.03	8.84
Schwann Cells, donor2	11578-120F3	3.40	13.61
Schwann Cells, donor3	11659-122F3	13.80	11.83
Sebocyte, donor1	11220-116B5	8.22	7.12
Sebocyte, donor2	11301-117B5	5.51	6.89
Sebocyte, donor3	11378-118B1	10.51	6.18
Sertoli Cells, donor1	11255-116F4	9.94	4.97
Sertoli Cells, donor2	11333-117F1	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	12.23	12.23
Skeletal Muscle Cells, donor2	11358-117H8	5.78	11.57
Skeletal Muscle Cells, donor3	11430-118G8	8.36	10.03
Skeletal Muscle Cells, donor4	11451-119A2	14.77	19.79
Skeletal Muscle Cells, donor5	11455-119A6	14.42	12.49
Skeletal Muscle Cells, donor6	11459-119B1	16.01	20.16
Skeletal Muscle Satellite Cells, donor1	11240-116D7	17.77	9.95
Skeletal Muscle Satellite Cells, donor2	11321-117D7	12.70	9.27
Skeletal Muscle Satellite Cells, donor3	11397-118D2	17.76	26.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	11.04	13.65
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.24	7.24
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	6.47	5.23
Skin - palm, donor1	10286-104F7	8.06	13.43
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.77	5.91
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	3.27	7.36
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.49	10.91
Small Airway Epithelial Cells, donor1	11256-116F5	6.95	16.54
Small Airway Epithelial Cells, donor2	11334-117F2	7.88	10.27
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	9.94	12.05
Small Airway Epithelial Cells, donor3	11406-118E2	12.59	17.01
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	13.58	5.55
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1.56	2.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	13.52	7.05
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.75	4.64
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.30	7.88
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	3.86
Smooth Muscle Cells - Bladder, donor1	11519-119H7	8.01	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.59	4.26
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.18	9.97
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	8.58	4.99
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	16.61	10.09
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	18.61	10.04
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.24	8.97
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	7.00	9.11
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.00	3.65
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.33	5.05
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.63	3.34
Smooth Muscle Cells - Colonic, donor1	11239-116D6	13.27	8.41
Smooth Muscle Cells - Colonic, donor2	11320-117D6	9.69	6.24
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.08	11.76
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.03	5.72
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	4.31
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.37	7.17
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	7.51	10.24
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	9.11	6.20
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	4.83	3.02
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	6.83	5.69
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2.42	4.83
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	19.07	25.43
Smooth Muscle Cells - Prostate, donor1	11257-116F6	7.86	8.39
Smooth Muscle Cells - Prostate, donor2	11335-117F3	8.64	6.76
Smooth Muscle Cells - Prostate, donor3	11465-119B7	13.19	7.36
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	12.51	9.65
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	5.25	3.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	3.88	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	9.77	9.77
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	6.06
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	3.45	3.13
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.19	4.72
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	17.83	15.74
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	13.55	8.41
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.33	4.03
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.20	7.39
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.58	5.45
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	13.42	12.16
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.57	8.46
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	4.76
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.12	4.65
Smooth Muscle Cells - Uterine, donor1	11258-116F7	7.29	5.97
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.29	7.02
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	6.41	3.30
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	7.93	5.29
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.30	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	8.98	4.31
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.52	5.11
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	12.60	14.57
Smooth muscle cells - airway, control, donor1	11966-126D4	7.11	3.81
Smooth muscle cells - airway, control, donor2	11967-126D5	10.38	3.59
Smooth muscle cells - airway, control, donor3	11968-126D6	10.87	3.76
Smooth muscle cells - airway, control, donor4	11969-126D7	13.75	5.50
Synoviocyte, donor1	11291-117A4	13.97	10.27
Synoviocyte, donor2	11368-117I9	11.57	6.20
Synoviocyte, donor3	11440-118H9	10.50	4.92
Trabecular Meshwork Cells, donor1	11532-120A2	11.43	10.01
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	7.93
Trabecular Meshwork Cells, donor3	11693-123A1	6.02	10.19
Tracheal Epithelial Cells, donor1	11292-117A5	8.39	13.48
Tracheal Epithelial Cells, donor2	11369-118A1	4.64	8.50
Tracheal Epithelial Cells, donor3	11441-118I1	2.29	5.73
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	23.25	11.69
Urethra, donor2	10319-105A4	16.19	10.79
Urothelial Cells, donor1	11520-119H8	6.91	8.24
Urothelial Cells, donor2	11600-120H7	8.41	5.61
Urothelial Cells, donor3	11681-122H7	5.27	6.19
Urothelial cells, donor0	11216-116B1	14.71	15.16
Whole blood (ribopure), donor090309, donation1	12179-129A1	44.49	7.12
Whole blood (ribopure), donor090309, donation2	12180-129A2	38.60	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	36.28	6.16
Whole blood (ribopure), donor090325, donation1	12176-128I7	17.56	5.17
Whole blood (ribopure), donor090325, donation2	12177-128I8	18.59	4.65
Whole blood (ribopure), donor090612, donation1	12182-129A4	29.15	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	32.12	7.34
Whole blood (ribopure), donor090612, donation3	12184-129A6	44.73	5.48
Wilms' tumor cell line:G-401	10809-111A8	18.01	13.69
Wilms' tumor cell line:HFWT	10597-108E3	18.48	22.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	39.66	21.23
achilles tendon, donor2	10292-104G4	6.20	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	18.61	28.05
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	30.88	33.43
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	27.66	28.85
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	22.59	57.69
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	26.70	34.29
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	23.26	17.13
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	20.42	28.58
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	22.91	21.59
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	13.88	14.70
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	23.69	20.58
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	17.30	29.44
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	11.70	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	18.13	16.73
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.31	13.72
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	19.58	19.87
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	9.76	11.15
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	23.44	8.64
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	12.89	12.89
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	10.67	10.67
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	11.22	9.40
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	8.42	9.63
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	11.36	17.15
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	16.01	18.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	30.89	56.12
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	35.33	29.66
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	43.11	37.49
adenocarcinoma cell line:IM95m	10796-110I4	24.73	10.36
adipose tissue, adult, pool1	10010-101C1	14.43	6.05
adipose, donor1	10184-103D4	41.05	8.21
adipose, donor2	10185-103D5	23.93	6.49
adipose, donor3	10186-103D6	28.59	10.07
adipose, donor4	10187-103D7	25.14	7.80
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	31.09	23.36
adrenal gland, adult, pool1	10081-102A9	7.28	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	22.41	22.95
alveolar cell carcinoma cell line:SW 1573	10708-109H6	19.65	6.79
amniotic membrane cells, donor1	12235-129G3	25.74	11.59
amniotic membrane cells, donor2	12236-129G4	36.18	16.23
amniotic membrane cells, donor3	12237-129G5	15.61	8.25
amygdala - adult, donor10196	10167-103B5	18.97	14.23
amygdala, adult, donor10252	10151-102I7	32.44	9.33
amygdala, newborn, donor10223	10360-105E9	8.71	9.36
anaplastic carcinoma cell line:8305C	10428-106D5	12.10	8.79
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	17.65	34.64
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	27.73	3.67
aorta, adult, pool1	10052-101G7	14.12	4.31
appendix, adult	10189-103D9	15.14	12.81
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	21.67	23.39
artery, adult	10190-103E1	19.02	12.23
astrocytoma cell line:TM-31	10425-106D2	17.96	10.58
b cell line:RPMI1788	10427-106D4	19.48	20.37
basal cell carcinoma cell line:TE 354.T	10702-109G9	18.31	10.54
bile duct carcinoma cell line:HuCCT1	10432-106D9	11.41	17.37
bile duct carcinoma cell line:TFK-1	10496-107C1	6.03	3.35
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	19.57	10.63
bladder, adult, pool1	10011-101C2	11.30	3.59
blood, adult, pool1	10053-101G8	48.72	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	17.98	5.14
bone marrow, adult	10192-103E3	12.15	3.37
brain, adult, donor1	10084-102B3	34.85	6.15
brain, adult, pool1	10012-101C3	22.94	7.13
brain, fetal, pool1	10085-102B4	21.37	21.37
breast carcinoma cell line:MCF7	10482-107A5	23.79	21.14
breast carcinoma cell line:MDA-MB-453	10419-106C5	21.10	7.61
breast, adult, donor1	10080-102A8	29.67	8.84
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	8.77	11.31
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	17.63	6.80
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	17.04	13.58
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	25.90	14.53
carcinoid cell line:NCI-H1770	10703-109H1	47.96	13.63
carcinoid cell line:NCI-H727	10735-110B6	21.44	25.16
carcinoid cell line:SK-PN-DW	10719-109I8	84.29	48.49
carcinosarcoma cell line:JHUCS-1	10642-109A3	30.34	14.37
caudate nucleus - adult, donor10196	10177-103C6	18.42	3.45
caudate nucleus, adult, donor10252	10164-103B2	23.26	5.69
caudate nucleus, adult, donor10258	10379-105H1	19.87	3.82
caudate nucleus, newborn, donor10223	10354-105E3	10.25	6.96
cerebellum - adult, donor10196	10173-103C2	61.18	2.91
cerebellum, adult, donor10252	10166-103B4	38.86	9.82
cerebellum, adult, pool1	10083-102B2	21.04	2.76
cerebellum, newborn, donor10223	10357-105E6	20.76	9.13
cerebral meninges, adult	10188-103D8	21.68	10.09
cerebrospinal fluid, donor2	10294-104G6	17.54	2.19
cervical cancer cell line:D98-AH2	10552-107I3	87.85	40.12
cervical cancer cell line:ME-180	10553-107I4	15.08	9.78
cervix, adult, pool1	10013-101C4	16.59	7.35
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	24.24	18.81
chondrosarcoma cell line:SW 1353	10700-109G7	10.45	2.61
choriocarcinoma cell line:BeWo	10423-106C9	35.67	28.96
choriocarcinoma cell line:SCH	10785-110H2	24.15	31.79
choriocarcinoma cell line:T3M-3	10618-108G6	9.72	18.74
chorionic membrane cells, donor1	12238-129G6	11.11	8.55
chorionic membrane cells, donor2	12239-129G7	19.09	10.84
chorionic membrane cells, donor3	12240-129G8	13.19	6.04
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	13.13	38.37
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	27.09	31.12
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	36.11	27.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	30.30	28.50
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	31.93	31.44
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	24.43	38.48
chronic myelogenous leukemia cell line:K562	10454-106G4	32.39	51.82
chronic myelogenous leukemia cell line:KU812	10409-106B4	43.79	69.59
clear cell carcinoma cell line:JHOC-5	10638-108I8	17.60	20.80
clear cell carcinoma cell line:TEN	10636-108I6	10.24	10.06
colon carcinoma cell line:CACO-2	10513-107D9	49.60	35.14
colon carcinoma cell line:COLO-320	10420-106C6	16.72	13.68
colon, adult, donor1	10082-102B1	19.04	7.14
colon, adult, pool1	10014-101C5	28.32	19.27
colon, fetal, donor1	10070-101I7	27.19	12.36
common myeloid progenitor CMP, donor1	12130-128D6	22.92	9.17
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	7.22	28.47
cord blood derived cell line:COBL-a 24h infection	10453-106G3	12.98	40.60
cord blood derived cell line:COBL-a untreated	10449-106F8	17.49	38.64
corpus callosum, adult, pool1	10042-101F6	33.39	7.19
cruciate ligament, donor2	10295-104G7	12.97	5.67
diaphragm, fetal, donor1	10069-101I6	26.48	9.63
diencephalon, adult	10193-103E4	23.52	4.56
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	13.09	19.06
ductal cell carcinoma cell line:KLM-1	10438-106E6	15.39	18.72
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	13.24	18.54
ductus deferens, adult	10196-103E7	32.89	22.43
duodenum, fetal, donor1, tech_rep1	10071-101I8	25.92	14.40
duodenum, fetal, donor1, tech_rep2	10071-101I8	21.33	8.83
dura mater, adult, donor1	10041-101F5	13.21	6.94
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	10.88	25.76
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	16.05	28.09
embryonic pancreas cell line:1B2C6	10604-108F1	10.48	6.17
embryonic pancreas cell line:1C3D3	10605-108F2	6.36	11.81
embryonic pancreas cell line:1C3IKEI	10606-108F3	6.79	8.34
embryonic pancreas cell line:2C6	10603-108E9	5.25	9.19
endometrial carcinoma cell line:OMC-2	10497-107C2	11.73	12.07
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	30.81	12.87
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	6.43	9.49
epidermoid carcinoma cell line:A431	10426-106D3	11.56	14.12
epidermoid carcinoma cell line:Ca Ski	10431-106D8	42.23	23.98
epididymis, adult	10197-103E8	18.42	10.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	31.93	10.47
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.19	19.27
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	14.94	23.33
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	16.14	22.54
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	18.60	26.10
esophagus, adult, pool1	10015-101C6	16.46	9.77
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	15.15	11.90
eye - muscle inferior rectus, donor1	10272-104E2	4.83	4.83
eye - muscle lateral, donor2	10298-104H1	14.73	4.21
eye - muscle medial, donor2	10299-104H2	20.84	5.95
eye - muscle superior, donor2	10297-104G9	18.34	4.59
eye - vitreous humor, donor1	10268-104D7	17.49	4.37
eye, fetal, donor1	10054-101G9	33.81	6.10
fibrosarcoma cell line:HT-1080	10758-110E2	8.21	11.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	21.61	28.25
frontal lobe, adult, pool1	10040-101F4	34.71	11.35
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	27.02	9.01
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	22.68	10.70
gall bladder, adult	10198-103E9	15.21	3.62
gamma delta positive T cells, donor1	11937-126A2	9.66	8.59
gamma delta positive T cells, donor2	11938-126A3	17.93	7.47
gastric adenocarcinoma cell line:MKN1	10614-108G2	8.03	15.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	10.25	13.93
gastric cancer cell line:AZ521	10549-107H9	23.45	27.71
gastric cancer cell line:GSS	10560-108A2	41.19	49.42
gastrointestinal carcinoma cell line:ECC12	10615-108G3	12.79	15.08
giant cell carcinoma cell line:LU65	10487-107B1	18.13	10.67
giant cell carcinoma cell line:Lu99B	10433-106E1	9.38	18.47
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.93	26.94
glioblastoma cell line:A172, tech_rep1	10444-106F3	10.24	8.34
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.97	6.88
glioblastoma cell line:T98G	10485-107A8	20.64	17.55
glioma cell line:GI-1	10413-106B8	12.30	7.91
globus pallidus - adult, donor10196	10175-103C4	31.34	2.19
globus pallidus, adult, donor10252	10161-103A8	49.31	7.32
globus pallidus, adult, donor10258	10367-105F7	19.17	1.37
globus pallidus, newborn, donor10223	10364-105F4	15.99	6.93
granulocyte macrophage progenitor, donor1	12131-128D7	39.15	51.39
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	26.13
granulosa cell tumor cell line:KGN	10624-108H3	7.36	2.56
hIPS +CCl2, biol_rep1	14383-156B9	25.25	10.10
hIPS +CCl2, biol_rep2	14384-156C1	12.80	14.63
hIPS +CCl2, biol_rep3	14385-156C2	31.56	13.53
hIPS, biol_rep1	14380-156B6	25.87	21.56
hIPS, biol_rep2	14381-156B7	19.20	15.77
hIPS, biol_rep3	14382-156B8	15.45	4.41
hairy cell leukemia cell line:Mo	10712-109I1	8.91	18.10
heart - mitral valve, adult	10205-103F7	13.45	5.38
heart - pulmonic valve, adult	10206-103F8	21.18	7.84
heart - tricuspid valve, adult	10207-103F9	9.16	10.82
heart, adult, diseased post-infarction, donor1	10050-101G5	26.73	11.43
heart, adult, diseased, donor1	10051-101G6	13.20	7.66
heart, adult, pool1	10016-101C7	18.40	13.80
heart, fetal, pool1	10046-101G1	28.13	11.60
hepatic mesenchymal tumor cell line:LI90	10778-110G4	13.58	4.01
hepatoblastoma cell line:HuH-6	10633-108I3	11.89	24.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	32.49	27.84
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	30.22	31.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.54	32.13
hepatoma cell line:Li-7	10484-107A7	9.56	9.79
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	17.09	23.42
hippocampus - adult, donor10196	10169-103B7	19.87	3.79
hippocampus, adult, donor10252	10153-102I9	41.64	9.18
hippocampus, adult, donor10258	10374-105G5	19.42	7.47
hippocampus, newborn, donor10223	10363-105F3	12.34	7.05
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	30.52	18.31
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	26.70	15.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	28.18	16.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	32.14	15.79
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	43.64	9.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	38.72	12.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	22.19	9.93
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	31.45	12.49
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	33.37	13.35
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	30.07	14.21
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	28.13	15.91
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	31.65	18.85
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	22.53	9.08
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	27.02	8.84
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	31.42	5.24
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	46.01	11.65
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	32.27	11.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	26.99	11.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	28.07	4.33
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	29.10	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	21.61	5.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	25.31	7.68
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	20.32	6.68
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	22.72	8.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	31.59	12.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.39	12.84
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	34.71	15.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	30.28	11.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	32.31	14.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	27.84	10.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	21.72	8.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	27.23	8.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	22.06	7.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	22.50	11.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	24.23	6.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	25.20	9.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	32.36	10.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	30.30	14.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	23.90	11.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.84	11.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	84.58	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	40.71	6.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	29.55	10.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.99	7.60
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	25.62	7.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	25.06	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	26.14	11.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	18.59	8.89
immature langerhans cells, donor1	11904-125F5	13.56	4.12
immature langerhans cells, donor2	11905-125F6	11.09	9.51
insula, adult, pool1	10039-101F3	35.96	11.64
keratoacanthoma cell line:HKA-1	10791-110H8	16.26	6.50
kidney, adult, pool1	10017-101C8	31.14	20.43
kidney, fetal, pool1	10045-101F9	21.43	15.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	7.10	9.37
large cell lung carcinoma cell line:NCI-H460	10839-111E2	6.91	8.43
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	25.14	16.70
left atrium, adult, donor1	10079-102A7	19.61	10.35
left ventricle, adult, donor1	10078-102A6	22.75	8.60
leiomyoblastoma cell line:G-402	10721-110A1	21.89	15.60
leiomyoma cell line:10964C	10569-108B2	5.75	1.44
leiomyoma cell line:15242A	10570-108B3	10.87	5.43
leiomyoma cell line:15425	10571-108B4	7.04	3.16
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	9.41
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	29.28	63.16
liposarcoma cell line:KMLS-1	10782-110G8	11.25	3.75
liposarcoma cell line:SW 872	10726-110A6	22.42	12.31
liver, adult, pool1	10018-101C9	23.66	21.23
liver, fetal, pool1	10086-102B5	11.29	7.53
locus coeruleus - adult, donor10196	10182-103D2	27.27	4.96
locus coeruleus, adult, donor10252	10165-103B3	34.51	7.57
locus coeruleus, adult, donor10258	10375-105G6	37.81	11.85
locus coeruleus, newborn, donor10223	10362-105F2	15.56	6.31
lung adenocarcinoma cell line:A549	10499-107C4	14.39	15.78
lung adenocarcinoma cell line:PC-14	10408-106B3	19.30	13.79
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	42.84	27.29
lung, adult, pool1	10019-101D1	16.42	6.85
lung, fetal, donor1	10068-101I5	15.41	8.28
lung, right lower lobe, adult, donor1	10075-102A3	20.62	5.96
lymph node, adult, donor1	10077-102A5	10.89	7.57
lymphangiectasia cell line:DS-1	10727-110A7	23.01	24.99
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	13.13	30.94
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	17.84	15.29
mature adipocyte, donor1	12231-129F8	47.95	9.32
mature adipocyte, donor2	12232-129F9	52.92	8.92
mature adipocyte, donor3	12233-129G1	46.23	8.30
mature adipocyte, donor4	12234-129G2	34.48	6.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	17.39	26.69
medial frontal gyrus - adult, donor10196	10170-103B8	29.33	10.15
medial frontal gyrus, adult, donor10252	10150-102I6	32.18	8.09
medial frontal gyrus, adult, donor10258	10368-105F8	20.01	9.53
medial frontal gyrus, newborn, donor10223	10352-105E1	16.21	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	38.48	13.33
medial temporal gyrus, adult, donor10252	10156-103A3	39.47	7.43
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	12.20	10.05
medulla oblongata - adult, donor10196	10174-103C3	25.96	4.54
medulla oblongata, adult, donor10252	10155-103A2	36.38	6.35
medulla oblongata, adult, pool1	10038-101F2	30.20	7.92
medulla oblongata, newborn, donor10223	10361-105F1	15.62	7.99
medulloblastoma cell line:D283 Med	10838-111E1	12.18	12.84
medulloblastoma cell line:ONS-76	10759-110E3	12.84	13.69
melanoma cell line:COLO 679	10514-107E1	22.14	19.98
melanoma cell line:G-361	10465-106H6	10.59	16.02
meningioma cell line:HKBMM	10691-109F7	6.33	11.58
merkel cell carcinoma cell line:MKL-1	10843-111E6	39.65	14.98
merkel cell carcinoma cell line:MS-1	10844-111E7	15.29	8.55
mesenchymal precursor cell - adipose, donor1	11747-123G1	18.26	13.66
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.72	10.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	10.77	7.45
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.96	3.23
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.05	3.27
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.25	4.16
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.28	15.28
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.73	7.02
mesenchymal precursor cell - cardiac, donor3	11754-123G8	13.13	6.76
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.56	13.23
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	11.81	5.83
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.77	12.84
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.69	6.09
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	16.41	7.68
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	11.43	5.72
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.19	9.35
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	9.00	4.45
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	5.47	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	8.39	10.49
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.60	6.13
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.03	7.97
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	15.83	5.52
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.87	6.30
mesenchymal stem cell line:Hu5/E18	10568-108B1	16.00	10.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	13.24	8.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	12.02	10.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.40	11.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.02	8.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.47	9.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.88	6.43
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	13.36	11.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	17.15	6.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.29	8.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.38	6.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.38	7.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.87	5.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	11.08	7.38
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.28	6.14
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.46	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	8.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	13.64	8.12
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.99	12.79
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.90	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.61	5.83
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	14.90	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.27	8.30
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	15.84	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.30	7.60
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	16.90	7.24
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	0.00	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.93	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.12	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.61	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.35	5.30
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	7.10
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	7.57	7.57
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.39	12.86
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	14.58	7.85
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	9.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.10	12.09
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	13.08
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	8.87	7.60
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.21	16.99
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	22.59
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	22.24	14.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	17.46	10.91
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	17.20	8.11
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	10.19
mesodermal tumor cell line:HIRS-BM	10696-109G3	15.47	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	19.84	29.29
mesothelioma cell line:ACC-MESO-4	10494-107B8	14.13	4.87
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	21.37
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	22.50	8.73
mesothelioma cell line:Mero-25	10850-111F4	3.86	20.43
mesothelioma cell line:Mero-41	10851-111F5	9.29	26.40
mesothelioma cell line:Mero-48a	10852-111F6	6.20	5.09
mesothelioma cell line:Mero-82	10853-111F7	11.56	18.40
mesothelioma cell line:Mero-83	10854-111F8	7.66	4.77
mesothelioma cell line:Mero-84	10855-111F9	5.31	21.74
mesothelioma cell line:Mero-95	10856-111G1	11.39	8.07
mesothelioma cell line:NCI-H2052	10847-111F1	6.13	8.12
mesothelioma cell line:NCI-H226	10846-111E9	11.58	12.49
mesothelioma cell line:NCI-H2452	10848-111F2	16.06	14.35
mesothelioma cell line:NCI-H28	10845-111E8	7.63	11.96
mesothelioma cell line:No36	10857-111G2	20.22	31.64
mesothelioma cell line:ONE58	10858-111G3	14.09	27.37
migratory langerhans cells, donor1	11901-125F2	8.83	8.83
migratory langerhans cells, donor2	11902-125F3	7.82	11.23
migratory langerhans cells, donor3	11903-125F4	12.03	9.51
mixed mullerian tumor cell line:HTMMT	10689-109F5	36.24	36.24
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.32	22.25
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	15.43	17.05
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	13.89	20.93
myelodysplastic syndrome cell line:SKM-1	10772-110F7	23.65	13.86
myeloma cell line:PCM6	10474-106I6	22.93	17.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	26.89	6.59
myxofibrosarcoma cell line:NMFH-1	10684-109E9	15.69	3.53
nasal epithelial cells, donor1, tech_rep1	12226-129F3	18.61	23.96
nasal epithelial cells, donor1, tech_rep2	12226-129F3	15.96	22.58
nasal epithelial cells, donor2	12227-129F4	9.38	19.87
neuroblastoma cell line:CHP-134	10508-107D4	20.94	14.49
neuroblastoma cell line:NB-1	10539-107G8	18.52	6.17
neuroblastoma cell line:NBsusSR	10607-108F4	21.30	30.58
neuroblastoma cell line:NH-12	10555-107I6	26.09	12.67
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	46.73	31.31
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	16.95	21.38
neuroectodermal tumor cell line:TASK1	10774-110F9	28.18	21.33
neuroepithelioma cell line:SK-N-MC	10728-110A8	29.25	43.87
neurofibroma cell line:Hs 53.T	10729-110A9	13.04	10.11
neutrophil PMN, donor1	12133-128D9	14.87	29.75
neutrophil PMN, donor2	12137-128E4	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	32.30	17.25
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	25.62	11.21
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	22.12	13.79
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	13.40	5.78
nucleus accumbens, adult, pool1	10037-101F1	27.28	7.87
occipital cortex - adult, donor10196	10172-103C1	24.72	4.12
occipital cortex, adult, donor10252	10163-103B1	44.01	6.71
occipital cortex, newborn, donor10223	10355-105E4	8.73	8.73
occipital lobe, adult, donor1	10076-102A4	26.24	8.13
occipital lobe, fetal, donor1	10073-102A1	47.20	21.88
occipital pole, adult, pool1	10036-101E9	18.45	6.78
olfactory region, adult	10195-103E6	32.67	8.60
optic nerve, donor1	10277-104E7	22.01	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	16.40	15.95
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	27.07	15.94
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	11.18	7.11
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.28	10.40
osteoclastoma cell line:Hs 706.T	10704-109H2	12.05	8.53
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	28.03	25.23
osteosarcoma cell line:HS-Os-1	10558-107I9	8.69	14.63
ovary, adult, pool1	10020-101D2	6.38	3.06
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.28	13.75
pancreas, adult, donor1	10049-101G4	31.98	21.63
pancreatic carcinoma cell line:NOR-P1	10698-109G5	16.21	19.29
papillary adenocarcinoma cell line:8505C	10437-106E5	12.27	23.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	8.11	6.29
paracentral gyrus, adult, pool1	10035-101E8	31.85	8.33
parietal cortex, adult, donor10258	10373-105G4	8.81	3.67
parietal lobe - adult, donor10196	10171-103B9	13.17	5.64
parietal lobe, adult, donor10252	10157-103A4	29.93	7.70
parietal lobe, adult, pool1	10034-101E7	30.84	9.34
parietal lobe, fetal, donor1	10072-101I9	34.91	16.49
parietal lobe, newborn, donor10223	10356-105E5	12.34	6.36
parotid gland, adult	10199-103F1	30.22	16.65
penis, adult	10200-103F2	12.89	5.37
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	20.45	26.03
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	8.89	12.09
pineal gland - adult, donor10196	10179-103C8	22.58	4.52
pineal gland, adult, donor10252	10160-103A7	55.08	15.40
pineal gland, adult, donor10258	10377-105G8	37.00	9.41
pituitary gland - adult, donor10196	10180-103C9	20.24	8.09
pituitary gland, adult, donor10252	10162-103A9	37.52	16.68
pituitary gland, adult, donor10258	10378-105G9	25.54	7.66
placenta, adult, pool1	10021-101D3	17.20	13.01
plasma cell leukemia cell line:ARH-77	10840-111E3	8.48	9.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.61	14.94
pons, adult, pool1	10033-101E6	33.14	9.55
postcentral gyrus, adult, pool1	10032-101E5	25.72	9.68
promyelocytes/myelocytes PMC, donor1	12132-128D8	23.01	41.83
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	22.03
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	29.86	13.69
prostate cancer cell line:PC-3	10439-106E7	23.96	19.42
prostate, adult, pool1	10022-101D4	11.06	6.17
putamen, adult, donor10196	10176-103C5	24.08	4.96
putamen, adult, donor10252	10152-102I8	29.41	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	16.39	9.84
putamen, adult, donor10258, tech_rep2	10372-105G3	21.50	5.56
putamen, newborn, donor10223	10365-105F5	11.24	4.50
rectal cancer cell line:TT1TKB	10469-106I1	24.44	28.22
rectum, fetal, donor1	10067-101I4	26.43	6.95
renal cell carcinoma cell line:OS-RC-2	10411-106B6	8.69	7.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.47	6.63
retina, adult, pool1	10030-101E3	41.45	11.83
retinoblastoma cell line:Y79	10475-106I7	43.39	19.23
rhabdomyosarcoma cell line:KYM-1	10787-110H4	16.11	8.73
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	25.03	23.62
sacrococcigeal teratoma cell line:HTST	10695-109G2	8.34	6.06
salivary acinar cells, donor1	11771-123I7	9.71	4.53
salivary acinar cells, donor2	11772-123I8	8.95	3.17
salivary acinar cells, donor3	11773-123I9	17.88	6.62
salivary gland, adult, pool1	10093-102C3	16.59	8.01
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	9.78	10.45
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	12.23	11.52
seminal vesicle, adult	10201-103F3	31.22	14.28
serous adenocarcinoma cell line:JHOS-2	10639-108I9	9.23	11.90
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.60	19.63
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	14.05	23.08
serous cystadenocarcinoma cell line:HTOA	10693-109F9	27.13	28.07
signet ring carcinoma cell line:Kato III	10436-106E4	20.23	27.63
signet ring carcinoma cell line:NUGC-4	10483-107A6	16.39	15.22
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	5.67
skeletal muscle, adult, pool1	10023-101D5	16.55	13.55
skeletal muscle, fetal, donor1	10066-101I3	10.05	5.03
skin, adult, donor1	10074-102A2	6.79	6.79
skin, fetal, donor1	10065-101I2	22.72	9.47
small cell cervical cancer cell line:HCSC-1	10800-110I8	29.68	23.35
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	25.22	8.83
small cell lung carcinoma cell line:DMS 144	10841-111E4	48.77	26.60
small cell lung carcinoma cell line:LK-2	10541-107H1	16.48	17.80
small cell lung carcinoma cell line:NCI-H82	10842-111E5	33.94	25.09
small cell lung carcinoma cell line:WA-hT	10562-108A4	64.07	35.08
small intestine, adult, pool1	10024-101D6	55.18	43.48
small intestine, fetal, donor1	10064-101I1	28.75	18.67
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	25.13	21.54
smooth muscle, adult, pool1	10048-101G3	9.56	2.07
somatostatinoma cell line:QGP-1	10781-110G7	28.95	14.74
spinal cord - adult, donor10196	10181-103D1	33.03	3.90
spinal cord, adult, donor10252	10159-103A6	42.58	7.89
spinal cord, adult, donor10258	10369-105F9	22.83	4.84
spinal cord, fetal, donor1	10056-101H2	28.66	9.15
spinal cord, newborn, donor10223	10359-105E8	15.61	5.51
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	13.74	12.10
spleen, adult, pool1	10025-101D7	17.51	11.12
spleen, fetal, pool1	10044-101F8	13.11	11.76
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	8.70	12.94
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.77	6.84
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	35.29	14.68
squamous cell carcinoma cell line:T3M-5	10616-108G4	4.30	4.69
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	13.28	8.78
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	23.72	38.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	31.31	24.54
stomach, fetal, donor1	10062-101H8	16.02	5.34
submaxillary gland, adult	10202-103F4	20.51	5.70
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	37.39	6.23
substantia nigra, adult, donor10258	10371-105G2	17.07	5.69
substantia nigra, newborn, donor10223	10358-105E7	13.42	3.53
synovial sarcoma cell line:HS-SY-II	10441-106E9	25.45	15.36
temporal lobe, adult, pool1	10031-101E4	24.07	10.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	61.97	23.50
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	32.09	15.82
tenocyte, donor1	11763-123H8	15.01	7.33
tenocyte, donor2	11765-123I1	9.92	4.20
tenocyte, donor3	11768-123I4	16.68	7.04
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	37.22	44.36
teratocarcinoma cell line:NCR-G1	10798-110I6	23.28	11.25
teratocarcinoma cell line:PA-1	10807-111A6	28.21	23.40
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	17.65	40.62
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	12.48	15.88
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	11.89	26.07
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	16.29	12.05
testis, adult, pool1	10026-101D8	8.91	11.06
testis, adult, pool2	10096-102C6	9.02	13.98
thalamus - adult, donor10196	10168-103B6	32.02	5.52
thalamus, adult, donor10252	10154-103A1	32.98	5.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	27.71	7.70
thalamus, adult, donor10258, tech_rep2	10370-105G1	27.17	9.22
thalamus, newborn, donor10223	10366-105F6	7.48	6.33
throat, adult	10209-103G2	18.23	9.49
throat, fetal, donor1	10061-101H7	31.08	7.01
thymic carcinoma cell line:Ty-82	10803-111A2	14.31	20.87
thymus, adult, pool1	10027-101D9	7.85	19.78
thymus, fetal, pool1	10043-101F7	10.08	15.79
thyroid carcinoma cell line:KHM-5M	10776-110G2	25.13	20.61
thyroid carcinoma cell line:TCO-1	10783-110G9	21.65	15.92
thyroid, adult, pool1	10028-101E1	27.25	10.08
thyroid, fetal, donor1	10060-101H6	44.82	12.66
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	12.32
tongue, adult	10203-103F5	20.23	14.42
tongue, fetal, donor1	10059-101H5	37.44	12.61
tonsil, adult, pool1	10047-101G2	17.83	12.32
trachea, adult, pool1	10029-101E2	14.23	11.53
trachea, fetal, donor1	10058-101H4	18.85	8.85
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.27	8.50
transitional-cell carcinoma cell line:5637	10418-106C4	15.60	15.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	99.65	117.99
tridermal teratoma cell line:HGRT	10694-109G1	13.32	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	7.03	7.03
umbilical cord, fetal, donor1	10057-101H3	14.61	6.26
uterus, adult, pool1	10100-102D1	12.11	7.68
uterus, fetal, donor1	10055-101H1	32.25	8.70
vagina, adult	10204-103F6	11.63	3.23
vein, adult	10191-103E2	13.15	8.33
xeroderma pigentosum b cell line:XPL 17	10563-108A5	9.88	11.48